MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

7 hedge funds and large institutions have $2.69M invested in Stealth BioTherapeutics Corp. ADS in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
KCM
1
Kingdon Capital Management
New York
$2.38M +$1.31M +219,716 +123%
Millennium Management
2
Millennium Management
New York
$158K -$56K -9,367 -26%
Bank of America
3
Bank of America
North Carolina
$98K -$97.3K -16,342 -50%
UBS Group
4
UBS Group
Switzerland
$40K +$27.6K +4,633 +223%
Morgan Stanley
5
Morgan Stanley
New York
$6K +$6K +1,000 New
Deutsche Bank
6
Deutsche Bank
Germany
$2K +$764 +133 +62%
CCA
7
Catalyst Capital Advisors
New York
-$7K -568 Closed